Substance Abuse in Women

Psychiatric Clinics of North America

Volumn 33, Issue 2, 2010, Pages 339-355

  Greenfield, Shelly F ^a   Back, Sudie E ^b   Lawson, Katie ^b   Brady, Kathleen T ^b  

^a MCLEAN HOSPITAL   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Addiction; Alcohol; Drug abuse; Gender; Substance use disorders; Women

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL DEHYDROGENASE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BACLOFEN; BUPRENORPHINE; ESTROGEN; LEVACETYLMETHADOL; METHADONE; METHAMPHETAMINE; NEFAZODONE; NICOTINE; PLACEBO; PRASTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SEX HORMONE; TETRAHYDROCANNABINOL;

ADDICTION; ALCOHOLISM; ANOREXIA NERVOSA; ANXIETY DISORDER; BULIMIA; CANNABIS ADDICTION; CLINICAL TRIAL; COCAINE DEPENDENCE; COMORBIDITY; DISEASE COURSE; DRUG DEPENDENCE; DRUG EFFICACY; EATING DISORDER; HUMAN; MAJOR DEPRESSION; MENSTRUAL CYCLE; MOOD DISORDER; NICOTINE REPLACEMENT THERAPY; OPIATE ADDICTION; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; TREATMENT CONTRAINDICATION;

ADULT; ANXIETY; COMORBIDITY; EATING DISORDERS; FEMALE; GONADAL STEROID HORMONES; HUMANS; MALE; MOOD DISORDERS; PSYCHOTHERAPY; RISK FACTORS; SEX FACTORS; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 77951485150     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2010.01.004     Document Type: Review

References (128)

1. Compton W.M., Thomas Y.F., Stinson F.S., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007, 64:566-576.
2. Kessler R.C., Chiu W.T., Demler O., et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005, 62(6):617-627.
3. Grucza R.A., Norberg K., Bucholz K.K., et al. Correspondence between secular changes in alcohol dependence and age of drinking onset among women in the United States. Alcohol Clin Exp Res 2008, 32(8):1493-1501.
4. Wagner F.A., Anthony J.C. Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend 2007, 86:191-198.
5. Helzer J.E., Burnam A., McEvoy L.T. Alcohol abuse and dependence. Psychiatric disorders in America: the epidemiological catchment area study 1991, 81-115. The Free Press, New York. L.N. Robins, D.A. Regier (Eds.).
6. Hasin D.S., Stinson F.S., Ogburn E., et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2007, 64(7):830-842.
7. Simoni-Wastila L., Ritter G., Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004, 39(1):1-23.
8. Blanco C., Alderson D., Ogburn E., et al. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002. Drug Alcohol Depend 2007, 90(2-3):252-260.
9. Hernandez-Avila C.A., Rounsaville B.J., Kranzler H.R. Opioid-, cannabis-, and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004, 74(3):265-272.
10. Hser Y.I., Anglin M.D., Booth M.W. Sex differences in addict careers: 3. Addiction. Am J Drug Alcohol Abuse 1987, 13(3):231-251.
11. Randall C.L., Roberts J.S., Del Boca F.K., et al. Telescoping of landmark events associated with drinking: a gender comparison. J Stud Alcohol 1999, 60:252-260.
12. Newman J.L., Mello N.K. Neuroactive gonadal steroid hormones and drug addiction in women. Women and addiction: a comprehensive handbook 2009, 35-64. Guilford Press, New York. K.T. Brady, S.E. Back, S.F. Greenfield (Eds.).
13. Doron R., Fridman L., Gispan-Herman I., et al. DHEA, a neurosteroid, decreases cocaine self-administration and reinstatement of cocaine-seeking behavior in rats. Neuropsychopharmacology 2006, 31(10):2231-2236.
14. Sofuoglu M., Dudish-Poulsen S., Nelson D., et al. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp Clin Psychopharmacol 1999, 7(3):274-283.
15. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31(3):659-674.
16. Perkins K.A., Levine M., Marcus M. Tobacco withdrawal in women and menstrual cycle phase. J Consult Clin Psychol 2000, 68(1):176-180.
17. Holdstock L., de Wit H. Effects of ethanol at four phases of the menstrual cycle. Psychopharmacology 2000, 150:374-382.
18. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology 2001, 142:343-351.
19. Sinha R., Fox H., Hong K.I., et al. Sex steroid hormones, stress response, and drug craving in cocaine-dependent women: implications for relapse susceptibility. Exp Clin Psychopharmacol 2007, 15(5):445-452.
20. Back S.E., Waldrop A.E., Saladin M.E., et al. Effects of gender and cigarette smoking on reactivity to psychological and pharmacological stress provocation. Psychoneuroendocrinology 2008, 33(5):560-568.
21. Fox H.C., Hong K.A., Paliwal P., et al. Altered levels of sex and stress steroid hormones assessed daily over a 28-day cycle in early abstinent cocaine-dependent females. Psychopharmacology 2008, 195(4):527-536.
22. Conway K.P., Compton W., Stinson F.S., et al. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006, 67:247-257.
23. Goldstein R.B. Comorbidity of substance use with independent mood and anxiety disorders in women: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Women and addiction: a comprehensive handbook 2009, 173-192. Guilford Press, New York. K.T. Brady, S.E. Back, S.F. Greenfield (Eds.).
24. Greenfield S.F. Assessment of mood and substance use disorders. Integrated treatment for mood and substance use disorders 2003, 432-467. Johns Hopkins University Press, Baltimore (MD). J. Westermeyer, R.D. Weiss, D. Ziedonis (Eds.).
25. Pettinati H.M., Dundon W., Lipkin C. Gender differences in response to sertraline pharmacotherapy in type A alcohol dependence. Am J Addict 2004, 13(3):236-247.
26. Hudson J.I., Hiripi E., Pope H.G., et al. The prevalence and correlated of eating disorders in the National Comorbidity Survey Replication Study. Biol Psychiatry 2007, 61:348-358.
27. Holderness C.C., Brooks-Gunn J., Warren M.P. Co-morbidity of eating disorders and substance abuse: review of the literature. Int J Eat Disord 1994, 16:1-34.
28. Dohm F.A., Striegal-Moore R., Wilfley D.E., et al. Self harm and substance use in a community sample of black and white women with binge eating disorders or bulimia nervosa. Intl J Eat Disord 2002, 32:389-400.
29. Bowers W.A., Andersen A.E., Evans K. Management of eating disorders: inpatient and partial hospital programs. Clinical handbook of eating disorders: an integrated approach 2004, 349-376. Marcel Dekker, New York. T.D. Brewerton (Ed.).
30. Gordon S.M., Johnson J.A., Greenfield S.F., et al. Assessment and treatment of co-occurring eating disorders in publicly funded addiction treatment programs. Psychiatr Serv 2008, 59:1056-1059.
31. Cottler L.B., Compton W.M., Mager D., et al. Post-traumatic stress disorder among substance users from the general population. Am J Psychiatry 1992, 149:664-670.
32. Mills K.L., Teesson M., Ross J., et al. Trauma, PTSD, and substance use disorders: findings from the Australian National Survey on mental health and well-being. Am J Psychiatry 2006, 163:652-658.
33. Najavits L.M., Weiss R., Shaw S. The link between substance abuse and posttraumatic stress disorder in women: a research review. Am J Addict 1997, 6(4):237-283.
34. Brady K.T., Dansky B.S., Back S.E., et al. Exposure therapy in the treatment of PSTD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat 2001, 21:47-54.
35. Back S.E., Dansky B.S., Carroll K.M., et al. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures. J Subst Abuse Treat 2001, 21(1):35-45.
36. Hien D.A. Trauma, posttraumatic stress disorder and addiction among women. Women and addiction: a comprehensive handbook 2009, 242-256. Guilford Press, New York. K.T. Brady, S.E. Back, S.F. Greenfield (Eds.).
37. Najavits L.M. Seeking safety: a treatment manual for PTSD and substance abuse 2002, Guilford Press, New York.
38. Brady K.T., Sonne S.C., Roberts J.M. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence. J Clin Psychiatry 1995, 56:502-505.
39. Brady K.T., Sonne S., Anton R.F., et al. Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder. Alcohol Clin Exp Res 2005, 29(3):395-401.
40. Labbate L.A., Sonne S.C., Randal C.L., et al. Does comorbid anxiety or depression affect clinical outcomes in patients with post-traumatic stress disorder and alcohol use disorders?. Compr Psychiatry 2004, 45(4):304-310.
41. Keyes K.M., Grant B.F., Hasin D.S. Evidence for a closing gender gap in alcohol use, abuse, and dependence in the United States population. Drug Alcohol Depend 2008, 93:21-29.
42. Brady K.T., Randall C.L. Gender differences in substance use disorders. Psychiatr Clin North Am 1999, 22:241-252.
43. Frezza M., Pozzato G., Chiesa L., et al. Abnormal serum gamma-glutamyltranspeptidase in alcoholics. Clues to its explanation. Neth J Med 1989, 34(1-2):22-28.
44. Annis H.M., Graham J.M. Profile types on the Inventory of Drinking Situations: implications for relapse prevention counseling. Psychol Addict Behav 1995, 9:176-182.
45. Stewart S.H., Gavric D., Collins P. Women, girls, and alcohol. Women & addiction 2009, 341-359. Guilford Press, New York. K.T. Brady, S.E. Back, S.F. Greenfield (Eds.).
46. Greenfield S.F., Brooks A.J., Gordon S.M., et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend 2007, 86:1-21.
47. Ashley O.S., Marsden M.E., Brady T.M. Effectiveness of substance abuse treatment programming for women: a review. Am J Drug Alcohol Abuse 2003, 29:19-53.
48. Dahlgren L., Willander A. Are special treatment facilities for female alcoholics needed? A controlled 2-year follow-up study from a specialized female unit (EWA) versus a mixed male/female treatment facility. Alcohol Clin Exp Res 1989, 13:499-504.
49. Greenfield S.F., Trucco E.M., McHugh R.K., et al. The Women's Recovery Group Study: a stage I trial of women-focused group therapy for substance use disorders versus mixed-gender group drug counseling. Drug Alcohol Depend 2007, 90:39-47.
50. Substance Abuse and Mental Health Services Administration (SAMHSA) Results from the 2008 National Survey on Drug Use and Health: national findings 2009, (Office of Applied Studies, NSDUH Series H-36, HHS Publication No. SMA 09-4434), US Department of Health and Human Services, Rockville (MD).
51. Lynch W.J. Sex differences in vulnerability to drug self-administration. Exp Clin Psychopharmacol 2006, 14(1):34-41.
52. Westermeyer J., Boedicker A.E. Course, severity, and treatment of substance abuse among women versus men. Am J Drug Alcohol Abuse 2000, 26(4):523-535.
53. Substance Abuse and Mental Health Services Administration Methamphetamine use. In the NSDUH report 2007, Office of Applied Studies, Rockville (MD).
54. Della Grotta S., LaGasse L.L., Arria A.M., et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 2009, Available at:, Accessed January 28, 2010. http://www.springerlink.com/content/l70457522w85q525/fulltext.html.
55. Terplan M., Smith E.J., Kozoloski M.J., et al. Methamphetamine use among pregnant women. Obstet Gynecol 2009, 113:1285-1291.
56. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol Biochem Behav 2004, 78(4):699-705.
57. Hser Y.I., Evans E., Huang Y.C. Treatment outcomes among women and men methamphetamine abusers in California. J Subst Abuse Treat 2005, 28(1):77-85.
58. Rowan-Szal G.A., Joe G.W., Simpson D.D., et al. During-treatment outcomes among female methamphetamine-using offenders in prison-based treatments. J Offender Rehabil 2009, 8:388-401.
59. Campbell U.C., Morgan A.D., Carroll M.E. Sex differences in the effects of baclofen on the acquisition of intravenous cocaine self-administration in rats. Drug Alcohol Depend 2002, 66(1):61-69.
60. Pettinati H.M., Kampman K.M., Lynch K.G., et al. Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence. J Subst Abuse Treat 2008, 34(4):378-390.
61. Elkashef A.M., Rawson R.A., Anderson A.L., et al. Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 2008, 33(5):1162-1170.
62. Center on Addiction and Substance Abuse at Columbia University (2005, July) Under the counter: the diversion and abuse of controlled prescription drugs in the U.S Available at:, Accessed September 15, 2008. http://www.casacolumbia.org/absolutenm/articlefiles/380-Under%20the%20Counter%20-%20Diversion.pdf.
63. Tetrault J.M., Desai R.A., Becker W.C., et al. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 2008, 103:258-268.
64. Colliver J.D., Kroutil L.A., Dai L., et al. Misuse of prescription drugs: data from the 2002, 2003, and 2004 National Surveys on Drug Use and Health 2006, (DHHS Publication No. SMA 06-4192, Analytic Series A-28), Substance Abuse and Mental Health Services Administration, Office of Applied Studies, Rockville (MD).
65. McCabe S.E., Cranford J.A., Boyd C.J., et al. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict Behav 2007, 32(3):562-575.
66. Back S.E., Payne R., Waldrop A.E., et al. Prescription opioid aberrant behaviors: a pilot study of gender differences. Clin J Pain 2009, 25:477-484.
67. Powis B., Griffiths P., Gossop M., et al. The differences between male and female drug users: community samples of heroin and cocaine users compared. Subst Use Misuse 1996, 31(5):529-543.
68. Kelly S.M., Schwartz R.P., O'Grady K.E., et al. Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug Alcohol Abuse 2009, 35(1):38-42.
69. Bryant J., Treload C. The gendered context of initiation to injecting drug use: evidence for women as active initiates. Drug Alcohol Rev 2007, 26:287-293.
70. Frajzyngier V., Neaigus A., Gyarmathy V.A., et al. Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend 2007, 89:145-152.
71. Breen C., Roxburgh A., Degenhardt L. Gender differences among regular injecting drug users in Sydney, Australia, 1996-2003. Drug Alcohol Rev 2005, 24:353-358.
72. Montgomery S.B., Hyde J., De Rosa C.J., et al. Gender differences in HIV risk behaviors among young injectors and their social network members. Am J Drug Alcohol Abuse 2002, 28(3):453-475.
73. Grant B.F., Moore T.C., Shepard J., et al. Source and accuracy statement for Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions 2003, National Institute on Alcohol abuse and Alcoholism, Bethesda (MD).
74. Najavits L.M., Rosier M., Nolan A.L., et al. A new gender-based model for women's recovery from substance abuse: results of a pilot outcome study. Am J Drug Alcohol Abuse 2007, 33(1):5-11.
75. Jones H.E., Fitzgerald H., Johnson R.E. Males and females differ in response to opioid agonist medications. Am J Addict 2005, 14:223-233.
76. Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey of Substance Abuse Treatment Services (N-SSATS) 2005, Department of Health and Human Services, Rockville (MD).
77. Substance Abuse and Mental Health Services Administration The NSDUH Report: daily marijuana users based on the 2003 National Survey on Drug Use and Health: national findings 2004, (Office of Applied Studies, NSDUH Series H-25, DHHS Publication No. SMA 04-3964), U.S. Department of Health and Human Services, Rockville (MD).
78. Van Etten M.L., Anthony J.C. Comparative epidemiology of initial drug opportunities and transitions to first use: marijuana, cocaine, hallucinogens, and heroin. Drug Alcohol Depend 1999, 54:117-125.
79. Gfroerer J.C., Wu L.T., Penne M.A. Initiation of marijuana use: trends, patterns, and implications 2002, (DHHS Publication No. SMA 02-3711, Analytic Series: A-17), Substance Abuse and Mental Health Administration, Office of Applied Studies, Rockville (MD).
80. Griffin M.L., Mendelson J.H., Mello N.K., et al. Marijuana use across the menstrual cycle. Drug Alcohol Depend 1986, 18:213-224.
81. Lex B.W., Mendelson J.H., Bavli S., et al. Effects of acute marijuana smoking on pulse rate and mood states in women. Psychopharmacology 1984, 84:178-187.
82. Terner J.M., de Wit H. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend 2006, 84:1-13.
83. Pope H.G., Gruber A.J., Hudson J.I., et al. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001, 58:909-915.
84. Pope H.G., Jacobs A., Mialet J.P., et al. Evidence for a sex-specific residual effect of cannabis on visuospatial memory. Psychother Psychosom 1997, 66:179-184.
85. Budney A.J., Higgins S.T., Radonovich P.L., et al. Adding voucher-based incentives to coping skills and motivational enhancement improves outcomes during treatment for marijuana dependence. J Consult Clin Psychol 2000, 68:1051-1061.
86. Haney M., Hart C.L., Ward A.S., et al. Nefazodone decreases anxiety during marijuana withdrawal in humans. Psychopharmacology 2003, 165:157-165.
87. Haney M., Hart C.L., Vosburg S.K., et al. Marijuana withdrawal in humans: effects of oral THC or divalproex. Neuropsychopharmacology 2004, 29:158-170.
88. Marijuana Treatment Project Research Group Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol 2004, 72:455-466.
89. Prescott E., Hippe M., Schnohr P., et al. Smoking and risk of myocardial infarction in women and men: longitudinal population study. Br Med J 1998, 316:1043-1047.
90. Dransfield M.T., Davis J.J., Gerald L.B., et al. Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:1110-1116.
91. International Early Lung Cancer Action Program Investigators Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer. JAMA 2006, 296:180-184.
92. Conklin C.A. Environments as cues to smoke: implication for human extinction-based research and treatment. Exp Clin Psychopharmacol 2006, 14:12-19.
93. Perkins K.A., Jacobs L., Sanders M., et al. Sex differences in the subjective and reinforcing effects of cigarette nicotine dose. Psychopharmacology 2002, 163:194-201.
94. Perkins K.A., Doyle T., Ciccocioppo M., et al. Sex differences in the influence of nicotine and dose instructions on subjective and reinforcing effects of smoking. Psychopharmacology 2006, 184:600-607.
95. Perkins K.A., Gerlach D., Vender J., et al. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob Res 2001, 3:141-150.
96. Centers for Disease Control and Prevention Cigarette smoking among adults-United States, 2005. MMWR Morb Mortal Wkly Rep 2006, 55:1145-1148.
97. Rodu B., Cole P. Declining mortality from smoking in the United States. Nicotine Tob Res 2007, 9:781-784.
98. Pirie P.L., Murray D.M., Luepker R.V. Gender differences in cigarette smoking and quitting in a cohort of young adults. Am J Public Health 1991, 81:324-327.
99. Swan G.E., Ward M.M., Carmelli D., et al. Differential rates of relapse in subgroups of male and female smokers. J Clin Epidemiol 1993, 46:1041-1053.
100. Munafo M., Bradburn M., Bowes L., et al. Are there sex differences in transdermal nicotine replacement therapy patch efficacy? A meta-analysis. Nicotine Tob Res 2004, 6:769-776.
101. Perkins K.A., Scott J. Sex differences in long-term smoking cessation rates due to nicotine patch. Nicotine Tob Res 2008, 10:1245-1251.
102. Gonzales D., Rennard S.I., Nides M., et al. Varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation. J Am Med Assoc 2006, 296:47-55.
103. Scharf D., Shiffman S. Are there gender differences in smoking cessation, with and without bupropion? Pooled and meta-analyses of clinical trials of Bupropion SR. Addiction 2004, 99:1462-1469.
104. Cepeda-Benito A., Reynoso J.T., Erath S. Meta-analysis of the efficacy of nicotine replacement therapy for smoking cessation: differences between men and women. J Consult Clin Psychol 2004, 72:712-722.
105. England L.J., Grauman A., Qian C., et al. Misclassification of maternal smoking status and effects on an epidemiologic study of pregnancy outcomes. Nicotine Tob Res 2007, 9:1005-1013.
106. McBride C.M., Pirie P.L. Postpartum smoking relapse. Addict Behav 1990, 15:165-168.
107. Office of Applied Studies, Substance Abuse and Mental Health Services Administration Treatment Episode Data Set (TEDS) highlights-2005 national admissions to substance abuse treatment services: 1995-2005 2006, SAMHSA, Rockville (MD), Available at:, Accessed November 8, 2007. http://oas.samhsa.gov/teds2k5/TEDSHi2k5.htm.
108. Green C.A., Polen M.R., Dickinson D.M., et al. Gender differences in predictors of initiation, retention, and completion in an HMO-based substance abuse treatment program. J Subst Abuse Treat 2002, 23:285-295.
109. Kelly P.J., Blacksin B., Mason E. Factors affecting substance abuse treatment completion for women. Issues Ment Health Nurs 2001, 22:287-304.
110. Loneck B., Garrett J., Banks S.M. Engaging and retaining women in outpatient alcohol and other drug treatment: the effect of referral intensity. Health Soc Work 1997, 22:38-46.
111. Schmidt L., Weisner C. The emergence of problem-drinking women as a special population in need of treatment. Recent developments in alcoholism: alcoholism and women 1995, 309-334. Plenum Press, New York. M. Galanter (Ed.).
112. Harrison PM, Beck AJ. 2005. Prisoners in 2004 (BJS Bulletin, NCJ 210677). Washington, DC: Bureau of Justice Statistics, US Department of Justice. Available at: Accessed October 10, 2006. http://www.ojp.gov/bjs/abstract/p04.htm.
113. Conners N.A., Bradley R.H., Mansell L.W., et al. Children of mothers with serious substance abuse problems: an accumulation of risks. Am J Drug Alcohol Abuse 2004, 30(1):85-100.
114. Grella C.E., Scott C.K., Foss M.A., et al. Gender differences in drug treatment outcomes among participants in the Chicago Target Cities Study. Eval Program Plann 2003, 26:297-310.
115. Lundgren L.M., Schilling R.F., Fitzgerald T., et al. Parental status of women injection drug users and entry to methadone maintenance. Subst Use Misuse 2003, 38(8):1109-1131.
116. Haller D.L., Miles D.R., Dawson K.S. Factors influencing treatment enrollment by pregnant substance abusers. Am J Drug Alcohol Abuse 2003, 29(1):117-131.
117. Chen X., Burgdorf K., Dowell K., et al. Factors associated with retention of drug abusing women in long-term residential treatment. Eval Program Plann 2004, 27:205-212.
118. Greenfield S.F., Grella C.E. Alcohol & drug abuse: what is " women-focused" treatment for substance use disorders?. Psychiatr Serv 2009, 60:880-882.
119. Orwin R.G., Francisco L., Bernichon T. Effectiveness of women's substance abuse treatment programs: a meta-analysis. Center for Substance Abuse Treatment 2001, SAMHSA, Arlington, Virginia.
120. Volpicelli J., Markman I., Monterosso J., et al. Psychosocially enhanced treatment for cocaine-dependent mothers: evidence of efficacy. J Subst Abuse Treat 2000, 18:41-49.
121. Smith W.B., Weisner C. Women and alcohol problems: a critical analysis of the literature and unanswered questions. Alcohol Clin Exp Res 2001, 24:1320-1321.
122. Condelli W.S., Koch M.A., Fletcher B. Treatment refusal/attrition among adults randomly assigned to programs at a drug treatment campus. The New Jersey Substance Abuse Treatment Campus, Seacaucus, NJ. J Subst Abuse Treat 2000, 18:395-407.
123. Strantz I.H., Welch S.P. Postpartum women in outpatient drug abuse treatment: correlates of retention/completion. J Psychoactive Drugs 1995, 27:357-373.
124. Kaskutas L.A., Zhang L., French M.T., et al. Women's programs versus mixed-gender day treatment: results from a randomized study. Addiction 2005, 100:60-69.
125. Greenfield S.F., Potter J.S., Lincoln M.F., et al. High psychiatric severity is a moderator of substance abuse treatment outcomes among women in single vs. mixed gender group treatment. Am J Drug Alcohol Abuse 2008, 34:594-602.
126. Cummings A, Gallop R. Self-efficacy and substance use outcomes for women in single gender versus mixed-gender group treatment. J Groups Addict Recover 2010, in press.
127. Connors G.J., Maisto S.A., Zywiak W.H. Male and female alcoholics' attributions regarding the onset and termination of relapses and the maintenance of abstinence. J Subst Abuse 1998, 10:27-42.
128. Fals-Stewart W., Birchler G.R., Kelley M.L. Learning sobriety together: a randomized clinical trial examining behavioral couples therapy with alcoholic female patients. J Consult Clin Psychol 2006, 74:579-591.